About Contact Us Careers
Sign In

Luteinizing Hormone Releasing Hormone (LHRH) Agonists Market - Top Companies and Manufacturers

  • Report ID: 3037
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Companies Dominating the Luteinizing Hormone Releasing Hormone (LHRH) Agonists Landscape

    • F. Hoffmann-La Roche Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Novartis Pharmaceuticals Corporation
    • Siemens Healthcare Private Limited
    • Pfizer Inc.
    • Clovis Oncology
    • Genomic Health, Inc.
    • Myriad Genetics, Inc.
    • MDxHealth
    • Tolmar Pharmaceuticals, Inc.
    • Ferring B.V.
Browse Key Market Insights with Data Illustration:

In the News


Author Credits:  Radhika Pawar


  • Report ID: 3037
  • Published Date: Sep 23, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The high effectiveness of LHRH agonists in prostate cancer is one of the major factors driving the market growth.

The market is anticipated to attain a significant CAGR over the forecast period, i.e., 2021-2029.

The concern for the side effects associated with the hormone is one of the major factors estimated to act as barriers to the growth of the market.

The major companies in the market are F. Hoffmann-La Roche Ltd, Novartis Pharmaceuticals Corporation, Siemens Healthcare Private Limited, Pfizer Inc., Clovis Oncology, Genomic Health, Inc., Myriad Genetics, Inc., and others.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample